2013
DOI: 10.1016/j.jcrc.2012.11.020
|View full text |Cite
|
Sign up to set email alerts
|

Changing trends in the use of seizure prophylaxis after traumatic brain injury: A shift from phenytoin to levetiracetam

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
45
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
4
3

Relationship

1
6

Authors

Journals

citations
Cited by 79 publications
(47 citation statements)
references
References 7 publications
2
45
0
Order By: Relevance
“…A recent increase in the use of levetiracetam for seizure prophylaxis has also been noted in adults (27). Several factors may underlie the growing use of levetiracetam, including the availability of an intravenous formulation, favorable side effect profile and minimal medication interactions.…”
Section: Discussionmentioning
confidence: 99%
“…A recent increase in the use of levetiracetam for seizure prophylaxis has also been noted in adults (27). Several factors may underlie the growing use of levetiracetam, including the availability of an intravenous formulation, favorable side effect profile and minimal medication interactions.…”
Section: Discussionmentioning
confidence: 99%
“…The selection process and reasons for exclusion are detailed in Figure 1. After applying the selection criteria, one RCT, two prospective cohort studies and six retrospective cohort studies were identified in the final analysis [15,20,[25][26][27][28][29][30][31]. …”
Section: Study Selectionmentioning
confidence: 99%
“…Information was obtained on mortality from four trials [20,[25][26][27]. There were 99 related deaths, of which 43 occurred in the LEV arm and 56 occurred in the PHT arm.…”
Section: Overall Mortalitymentioning
confidence: 99%
See 1 more Smart Citation
“…These medications include fosphenytoin, valproic acid, levetiracetam, and lacosamide. For many years, phenytoin and then fosphenytoin were the initial AEDs used in patients with SDH, but in recent years levetiracetam has been used increasingly due to its favorable pharmacology and tolerability [60]. There are no controlled studies aimed specifically at addressing the role, duration of treatment, and type of AEDs used with SDH.…”
Section: Treatmentmentioning
confidence: 99%